← Back to Clinical Trials
Recruiting NCT05819801

NCT05819801 Effect of Fasting on Patient Outcomes After Wide-Awake, Local Anesthesia-only, No Tourniquet (WALANT) Procedures

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05819801
Status Recruiting
Phase
Sponsor University of California, Irvine
Condition Surgery
Study Type INTERVENTIONAL
Enrollment 134 participants
Start Date 2024-02-22
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Non-fastingFasting

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 134 participants in total. It began in 2024-02-22 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to determine whether eating solid food prior to undergoing a wide awake local-only no tourniquet (WALANT) procedure reduces anxiety in patients or has any effect on outcomes. Patients will be split randomly into two groups and told whether to eat or fast before their procedure. We will then compare levels of anxiety and nausea on the day of the procedure as well as satisfaction with the procedure and other outcome measures at follow-up visits. Our hypothesis is that patients who are instructed to eat before their WALANT procedure will have less anxiety, nausea, and overall higher satisfaction compared to those who are instructed to fast prior to their procedure.

Eligibility Criteria

Inclusion Criteria: * Patients undergoing wide-awake, local anesthetic-only, no-tourniquet (WALANT) procedures with the lead researcher. Exclusion Criteria: * Patients with insulin-dependent diabetes or allergy to local anesthesia, \< 18 years of age, patients unable to follow up.

Contact & Investigator

Central Contact

Michael W Madsen, BA

✉ mwmadsen@hs.uci.edu

📞 2083090808

Principal Investigator

Jesse Kaplan, MD

PRINCIPAL INVESTIGATOR

UCI School of Medicine

Frequently Asked Questions

Who can join the NCT05819801 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05819801 currently recruiting?

Yes, NCT05819801 is actively recruiting participants. Contact the research team at mwmadsen@hs.uci.edu for enrollment information.

Where is the NCT05819801 trial being conducted?

This trial is being conducted at Orange, United States.

Who is sponsoring the NCT05819801 clinical trial?

NCT05819801 is sponsored by University of California, Irvine. The principal investigator is Jesse Kaplan, MD at UCI School of Medicine. The trial plans to enroll 134 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology